Abstract
We evaluated the clinical effectiveness of ceruletide in patients with dementia of the Alzheimer type and its effects on neurotransmitters in cerebrospinal fluid. Mini mental state scores were significantly increased after ceruletide administration. Acetylcholinesterase activity in cerebrospinal fluid was significantly increased after administration, while somatostatin and monoamine metabolites showed no significant changes. Ceruletide improved intellectual function, and the improvement seemed to be due to activation of neurotransmitters in the acetylcholine system in the brain. Though the subjects were elderly patients, no side effects presenting clinical problems were observed. This warrants further detailed studies on the effectiveness of ceruletide in dementia of the Alzheimer type.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
